Introduction
Colorectal cancer incidence is 35% lower in women than men (1) . Although the basis for this difference is unknown, gonadal steroids are considered a contributing factor. In women, high parity, early age at first pregnancy, oral contraceptive use and estrogen replacement therapy are each associated with decreased colorectal cancer risk (2) (3) (4) . In the Women's Health Initiative study, hormone replacement therapy conferred a 40% reduction in colorectal cancer risk (5) . Altogether, these data suggest that estrogens and/or progestins protect against colorectal cancer.
Consistent with the hypothesis that estrogens protect against colorectal cancer, administration of either a synthetic estrogen or the naturally occurring 17b-estradiol (E2) inhibits carcinogen-induced gastrointestinal tumorigenesis in rats (6, 7) . Similarly, E2 attenuates intestinal tumorigenesis in Apc Min/þ mice (8, 9) , in which inheritance of the multiple intestinal neoplasia (Min) mutation in the adenomatous polyposis coli (Apc) gene predisposes carriers to spontaneous intestinal tumorigenesis (10, 11) . The effects of estrogens are mediated by estrogen receptors (ERs) [ERa (Esr1) and ERb (Esr2)], which function as ligand-dependent transcription factors. Both receptors are expressed in the intestinal epithelium (12) (13) (14) (15) , but their function in this tissue is not known. Loss of ERa expression due to promoter hypermethylation occurs in colorectal cancers in both men and women (13) , suggesting that ERa functions as a tumor suppressor in the colon. ERa promoter hypermethylation occurs in normal colonic epithelium during aging (13, 16) and is postulated to create a microenvironment permissive to carcinogenesis. In contrast, loss of ERb expression correlates with advanced Dukes stages (17) .
Some support for the hypothesis that ERa and ERb impact intestinal tumorigenesis has been obtained from studies using Apc Min/þ mice. In one study, heterozygosity for an ERa knockout allele (Esr1 Pcn1 ) was associated with increased incidence of colon tumors in Apc Min/þ mice (18) . The impact of homozygosity for this ERa knockout allele (ERa À/À ) on tumorigenesis in Apc Min/þ mice could not be evaluated because no ERa À/À mice carrying the Apc Min/þ mutation were obtained from the intercross. Although two studies have examined the impact of an ERb knockout allele (Esr2 Pcn1 ) on tumorigenesis in Apc Min/þ mice, the results of these studies are strikingly different. In one study, heterozygosity and homozygosity for the ERb knockout allele were associated with increased incidence of colon tumors (18) . In the second study, this same ERb knockout allele had no impact on colon tumorigenesis (19) . Rather, these investigators observed that homozygosity for the ERb knockout was associated with an increase in small intestinal tumor number in Apc Min/þ female but not male mice (19) . Altogether, these results do support the idea that disruption of ERa and ERb signaling promotes intestinal tumorigenesis in Apc Min/þ mice. However, because a crucial genotypic class was absent in the ERa study and the two ERb studies yielded disparate results, the nature of the impact of ERa and ERb signaling on intestinal tumorigenesis remains largely unknown.
In the present study, we sought to clarify the role of ER signaling in tumorigenesis in the Apc Min/þ mouse by crossing targeted disruptions of ERa and ERb that are distinct from those used in the previous studies described above with the Apc Min strain. We intercrossed these ERa and ERb knockout strains with the Apc Min strain and evaluated their impact on intestinal tumorigenesis. The impact of these knockouts on the activity of the Wnt-b-catenin pathway in Apc Min/þ mice was also evaluated. Our data indicate that loss of ERa is associated with increased adenoma multiplicity in Apc Min/þ mice, whereas loss of ERb increases the incidence of colon tumors in Apc Min/þ mice without significantly altering tumor multiplicity. Loss of ERa but not ERb is associated with activation of Wnt-b-catenin signaling in the intestinal epithelium of Apc Min/þ mice. These studies suggest that both ERa and ERb modulate colorectal carcinogenesis, and ERa does so, at least in part, by regulating the Wnt-b-catenin pathway. mice. Similar crosses were performed with the ERb knockout. The ERa and Apc genotypes were determined by polymerase chain reaction (PCR) as described previously (20, 22) . ERb genotype was determined by PCR using neo primers (20) and primers that amplify ERb exon 3 (forward primer 5#-AGAG-ACCCTGAAGAGGAAGC-3# and reverse primer 5#-GCTTCTTTTAAAA-AAGGCCT-3#) only in the absence of the neo insert. The first ERb cross was conducted at the University of Helsinki. The Laboratory Animal Ethics Committee of the Faculty of Agriculture and Forestry, University of Helsinki, approved this study protocol. Apc Min/þ mice on a C57BL/6J (B6) genetic background were obtained from The Jackson Laboratory. Mice from the B6.129-Esr2 tm1Ksk strain (21) that was heterozygous for the ERb knockout (ERb þ/À ) mice were serially backcrossed to B6 mice. Mice were genotyped at Apc and ERb using PCR-based assays as described previously (22, 23 5 .5% fiber and no alfalfa or soybean meal. In this diet, the level of natural phytoestrogens is negligible. Animals were housed in plastic cages in a temperature-and humidity-controlled animal facility, with 12 h light-dark cycle. Food and water were provided ad libitum.
Materials and methods

Care and treatment of mice
Analysis of tumor multiplicity, size and histology Mice were euthanized by CO 2 asphyxiation. Intestinal tumors were counted and measured as described previously (10, (24) (25) (26) except that the small intestine was cut into four segments of equal length and the entire length of these segments, along with the colon, was examined. In Omaha crosses, segments of intestinal tissue fixed in 10% neutral buffered formalin were processed, sectioned and stained with hematoxylin and eosin. Stained sections were examined by an observer blinded with respect to the ER genotype. For intestinal tissue used for extraction of RNA or protein, adenomas were excised under the stereomicroscope at Â10 magnification. The remaining normal epithelium was scraped from the submucosal smooth muscle, frozen in liquid nitrogen and stored at À70°C.
Quantitative reverse transcription-PCR Total RNA was prepared using the Absolutely RNA miniprep kit (Stratagene Corporation, La Jolla, CA). Reverse transcription reactions were performed as described previously (27) . For Cyclin D1 and c-Myc complementary DNA, PCR was performed using 900 nM each primer and 200 nM probe. The primer and probes sequences were as follows: 5#-TCCGCAAGCATGCACAGA-3# (Cyclin D1 forward primer); 5#-CTTTGTGGCCCTCTGTGCCACAGA-3# (Cyclin D1 probe); 5#-GGTGGGTTGGAAATGAACTTCA-3# (Cyclin D1 reverse primer); 5#-TGAGCCCCTAGTGCTGCAT-3# (c-Myc forward primer); 5#-AGGAGACACCGCCCACCACCAG-3# (c-Myc probe) and 5#-CCTCAT-CTTCTTGCTCTTCTTCAGA-3# (c-Myc reverse primer). PCR was performed and analyzed using the ABI 7500 Real-Time PCR System and Sequence Detection Software version 1.9 (Applied Biosystems, Foster City, CA) as described previously (27) . Transcript abundance was normalized to glyceraldehyde 3#-phosphate dehydrogenase (Gapdh) (27) . Neither the Apc Min mutation nor the ERa deficiency impacted Gapdh expression (data not shown).
Determination of genotype at polymorphic markers Oligonucleotide primers specific to simple sequence length polymorphism repeats polymorphic in length between the 129P2 and the B6 strains were used for genotyping as described previously (27, 28) . Radioimmunoassay E2 and progesterone in unextracted sera collected at killing were measured using a coated tube radioimmunoassay (Diagnostic Products Corp., Los Angeles, CA) as described previously (29) . Samples were assayed in duplicate.
Min/þ mice, E2 measurements were obtained during the follicular phase of estrous and progesterone measurements were obtained during the luteal phase. Phase of estrous was determined based on ovarian histology. ERa À/À females do not cycle normally and are anovulatory; E2 measurements were made in these mice without selection for phase of estrous.
Immunoblotting
Mucosal scrapings were isolated in ice-cold phosphate-buffered saline supplemented with protease and phosphotase inhibitors. Nuclear and cytoplasmic extracts from fresh tissue were prepared using the Nuclear Extract kit (Active Motif, Carlsbad, CA) according to the manufacturer's instructions. Whole-cell extracts were prepared from frozen tissue and the same kit using manufacturer's instructions. Western blots were performed as described previously (30) except that the Li-Cor Odyssey Imaging system (Li-Cor, Lincoln, NE) was used. The antibodies used were as follows: E-5 b-catenin and MS-3 nucleolin mouse monoclonal antibodies and I-19 actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA); a-tubulin mouse monoclonal antibody, clone B-5-1-2 (Sigma Corporation, St. Louis, MO) and secondary antibodies labeled either with Alexa fluorÒ 680 (Invitrogen Corporation, Carlsbad, CA) or with IRDye800 TM (Rockland Immunochemicals, Gilbertsville, PA). Primary and secondary antibodies were used at a dilution of 1:1000 and 1:2000, respectively.
Quantitative assay for Apc locus DNA was isolated from normal intestinal epithelium scrapings. The quantitative PCR assay for the Apc locus was performed and analyzed as described previously (31) . For this assay, the Apc þ and Apc Min alleles are amplified and digested with HindIII, resulting in a 123 bp product from the Apc þ allele and a 144 bp product from the Apc Min allele. Radiolabeled products were resolved on a 5% denaturing polyacrylamide gel and quantitated using a Molecular Dynamics PhosphorImager and ImageQuaNT 5.0 software (GE Healthcare, Piscataway, NJ).
Statistical analysis
Average tumor multiplicity, tumor diameter and tumor burden were compared using the Wilcoxon rank sum test. Differences in the distribution of tumors along the intestine were evaluated with the chi-square test. Tumor incidence data were compared using Fisher's exact test. Differences in gene expression were evaluated using a t-test. All statistical analyses were conducted using SPSS software, version 13 (SPSS, Chicago, IL). P 0.05 was considered to be significant.
Results
ERa deficiency enhances Apc Min -induced tumorigenesis
To examine the impact of disrupting ERa in Apc Min/þ mice, we intercrossed the ERa knockout and Apc Min mouse strains. All genotypes of F 2 progeny were obtained at the expected frequencies (P . 0.05; data not shown). Mice were killed at 80 days of age. Mean tumor multiplicity in ERa þ/þ Apc Min/þ mice was 37.9 ( Figure 1A ). Mean tumor multiplicity in ERa þ/À Apc Min/þ mice was 37.1 and did not differ from that in ERa þ/þ Apc Min/þ mice (P . 0.05; Figure 1A ). Relative to ERa þ/þ Apc Min/þ and ERa þ/À Apc Min/þ mice, the mean adenoma multiplicity in ERa À/À Apc Min/þ mice was increased by 50% to 56.4 (P 5 0.01; Figure 1A ). Gender did not impact tumor multiplicity ( Figure 1B ; P . 0.05). ERa genotype did not alter the distribution of adenomas along the length of the intestine ( Figure 1C ; P . 0.05).
To examine the effect of ERa deficiency on tumor size, we focused on small intestinal adenomas because these lesions are flat; therefore, tumor diameter and/or tumor area are used as indicators of tumor size (25) . The mean tumor area in ERa þ/þ Apc Min/þ mice did not differ significantly from that in ERa þ/À Apc Min/þ mice (P . 0.05). In contrast, the average tumor area in ERa À/À Apc Min/þ mice was significantly larger than that in either ERa þ/þ or ERa þ/À mice (P 0.001). Combining tumor multiplicity and tumor size data, we calculated tumor burden. The average tumor burden in ERa þ/þ Apc Min/þ mice averaged 70 ± 23 mm 2 . The mean tumor burden in ERa þ/À Apc Min/þ mice of 81 ± 14 mm 2 did not differ significantly from that in ERa þ/þ Apc Min/þ mice (P . 0.05; Figure 1D ). In contrast, the mean tumor burden of 143 ± 28 mm 2 in ERa À/À Apc Min/þ was significantly greater than that in ERa þ/þ and ER þ/À mice (P , 0.005; Figure  1D ). ERa genotype did not impact adenoma histology in Apc Min/þ mice (Figure 2A and B) .
Impact of ERa deficiency on E2 levels and ovarian histology in Apc Min/þ mice ERa deficiency in female Apc þ/þ mice is associated with a 10-fold elevation in serum E2 by 60-120 days of age (32) . These observations raised the possibility that ERa deficiency might modulate tumorigenesis via an unknown mechanism driven by high levels of E2. Therefore, we examined serum E2 levels in ERa À/À Apc Min/þ females. We observed that in 80-day-old ERa À/À Apc Min/þ females, the mean serum E2 concentration was 32 ± 7 pg/ml. This value is at the low end of the normal physiological range of E2 in female mice, which varies from 20 to 100 pg/ml depending upon the phase of estrous. Thus, the enhanced intestinal tumorigenesis in female ERa À/À Apc Min/þ mice is not a consequence of high serum E2.
We postulated that ERa À/À Apc Min/þ females might exhibit low levels of serum E2 as a result of deleterious effects of the Apc Min mutation on ovarian function. In the estrus phase, when E2 levels are highest, the mean concentration of serum E2 in 80-day-old ERa þ/þ Apc Min/þ mice is ,20 pg/ml, the lower limit of detection of the assay used. In contrast with ERa þ/þ Apc þ/þ females ( Figure 2C ), ERa þ/þ Apc Min/þ females at 80 days of age possess ovaries exhibiting a high degree of follicular degeneration ( Figure 2D ) and few corpora lutea ( Figure 2E ; P 0.05). ERa þ/þ Apc Min/þ females also exhibit low-serum progesterone levels ( Figure 2F ; P 0.05), indicating reduced ovarian function. Although ovaries in ERa À/À Apc Min/þ mice showed the enlarged, hemorrhagic and cystic follicles ( Figure 2G ) characteristic of ERa À/À Apc þ/þ females [ Figure 2H ; (32)], these follicles in ERa À/À Apc Min/þ females did not show the hypertrophied theca, indicative of leutinizing hormone stimulation, frequently seen in older ERa À/À Apc þ/þ females.
Potential impact of 129-derived loci in the ERa knockout cross?
We genotyped our B6.129-Esr1 tm1Ksk founders using markers distributed across the genome (Table I) to identify residual 129P2 alleles even though this strain had been backcrossed for 12 generations. In these founders, the only 129P2 alleles detected were at three markers linked to ERa on proximal chromosome 10. The 129P2 alleles at these markers were segregating in the F 2 intercross mice ( Figure 3 ). Although 70% of ERa À/À Apc Min/þ mice retained the 129 allele at D10Mit152, the marker most closely linked to ERa, linkage disequilibrium dropped off sharply distal of this marker. Genotype at D10Mit51, the next marker distal of D10Mit152, exhibited poor concordance with ERa genotype. Only 10% of ERa À/À mice were homozygous for the 129P2 allele at D10Mit51, indicating that the 129P2 allele at this marker is not in disequilibrium with the 129P2-derived ERa knockout allele. All mice evaluated were homozygous for the B6 allele at markers including and distal to D10Mit87. Thus, ,13 Mbp from the 129P2 genome on chromosome 10 is retained in association with the ERa knockout.
ERa deficiency is associated with an accumulation of nuclear b-catenin and increased expression of Wnt-b-catenin target genes The Wnt-b-catenin pathway is constitutively activated in virtually all colon cancers. Although the impact of estrogen on Wntb-catenin activity in the intestine is not known, estrogens do influence this pathway in other tissues (33) (34) (35) (36) . These data, together with our observations that ERa deficiency enhanced intestinal tumorigenesis, led us to postulate that ERa deficiency might activate Wnt-b-catenin signaling in the intestinal epithelium of Apc Min/þ mice. In whole-cell extracts, b-catenin expression was higher in normal intestinal epithelium of ERa À/À Apc Min/þ mice relative to ERa þ/þ Apc Min/þ mice ( Figure 4A ). Nuclear accumulation of b-catenin, a molecular indicator of activation of Wnt-b-catenin signaling, was also evaluated. Quantitative analysis of these western blots indicated that nuclear b-catenin is increased by, on average, 60% in intestinal epithelium of ERa À/À Apc Min/þ mice relative to ERa þ/þ Apc Min/þ mice ( Figure 4B ), consistent with an increased activation of Wnt-b-catenin signaling in the absence of ERa. Expression of Cyclin D1 and c-Myc, two transcriptional targets of the Wnt-b-catenin pathway, was increased on average 2.2-fold and 2.4-fold, respectively, in the intestinal epithelium of ERa À/À Apc Min/þ mice relative to ERa þ/þ Apc Min/þ mice ( Figure 4C ), lending further support to the hypothesis that ERa deficiency is associated with increased Wnt-b-catenin signaling.
To verify that the normal intestinal epithelium specimens used in these analyses did not contain microadenomas, small precursors of adenomas that have lost wild-type Apc allele (Apc þ ) and thus exhibit increased nuclear b-catenin (37), we used a quantitative assay to determine the relative abundance of the Apc þ and Apc Min alleles in genomic DNA isolated from these specimens. It has been reported that in histologically normal intestinal epithelium of B6 Apc Min/þ mice, the mean Apc þ :Apc Min ratio value was 0.83 ± 0.18 (31) . Because microadenomas and adenomas in B6 Apc Min/þ mice exhibit loss of the Apc þ allele (31), contamination of normal tissue with these lesions would reduce the Apc þ :Apc Min ratio. Here, normal intestinal epithelium samples from ERa þ/þ Apc Min/þ mice yielded a mean Apc þ :Apc Min ratio value of 0.78 ± 0.24 ( Figure  4D ). A mean Apc þ :Apc Min ratio value of 0.90 ± 0.21 was obtained from normal intestinal epithelium samples from ERa À/À Apc Min/þ mice ( Figure 4D ). The mean Apc þ :Apc Min ratio values from ERa þ/þ Apc Min/þ in mice did not differ significantly from the value ERa À/À Apc Min/þ mice (P . 0.05), and both means were consistent with the value reported previously (31) . This result indicates that the normal epithelium samples used were not contaminated with microadenomas.
Effect of deletion of ERb on tumorigenesis in Apc Min/þ mice
To evaluate the effect of ERb deletion on tumor formation in Apc Min/þ mice, we intercrossed ERb þ/À mice with Apc Min/þ mice. In this intercross (Helsinki intercross), tumor multiplicity was evaluated at 90 days of age. ERb genotype did not have a significant impact on the mean number of adenomas in either the entire intestinal tract (data not shown; P ! 0.05) or the small intestine alone ( Figure 5A ; P ! 0.05). Because ERb is thought to play a role during the later stages of colorectal cancer progression, a second set of intercross mice was produced and evaluated at 140 days of age. This second set of intercross mice (Omaha intercross) was performed at a separate institution. However, both intercrosses involved the same ERb knockout (Esr2 Ksk1 ) and Apc Min/þ alleles, both of which were extensively backcrossed to the B6 strain. Consistent with our observation in the first set of intercross mice, ERb deficiency did not impact total tumor multiplicity (data not shown; P ! 0.05) or small intestinal tumor multiplicity ( Figure 5B ; P ! 0.05) in the second intercross population.
Analysis of the tumorigenesis in the colon indicated that ERb genotype had no significant effect on the mean number of adenomas in the colon at 90 days of age ( Figure 5C ; P 5 0.06-0.20) or 140 days of age ( Figure 5D ; P ! 0.05). In contrast, the 100% (14/14) incidence of colon tumors in 90-day-old Apc Min/þ ERb À/À mice was greater than the 57% (8/14) incidence in age-matched Apc Min/þ ERb þ/þ mice ( Figure 5E ; P , 0.01) and the 68% (13/19) incidence in age-matched Apc Min/þ ERb þ/À mice ( Figure 5E ; P , 0.05). ERb had no impact on colon adenoma incidence in the Omaha intercross mice evaluated at 140 days of age ( Figure 5F ; P ! 0.05). These markers were mapped proximal to Esr1 but the physical mapping places these markers distal to Esr1. Genetic and physical mapping data obtained from mouse genome informatics. 129 alleles at these markers were segregating in N 12 mice from the B6.129-Esr1 tm1Ksk strain. g (ERa) indicates that this marker was evaluated in mice derived from B6.129-Esr1 tm1Ksk strain.
ER disruption enhances Min-induced tumorigenesis
Potential impact of 129P2-derived loci in the ERb knockout crosses?
To assess the potential impact of residual 129P2 alleles present in the ERb intercross populations, we genotyped the B6.129-Esr2 tm1Ksk mice used in each study with markers distributed across the genome (Table I) to identify 129P2-derived regions. In the Helsinki intercross, 129P2 alleles were detected at only two markers-one unlinked to ERb (D1Mit206) and one linked to ERb (D12Mit91) ( Table I) . At these two markers, Apc Min/þ ERb þ/þ , Apc Min/þ ERb þ/À and Apc Min/þ ERb À/À intercross mice were either homozygous for the B6 allele or heterozygous. Genotype at these markers had no significant impact on total adenoma number in the intercross mice (data not shown; P 5 0.3). Likewise, genotype at these markers did not have a significant impact on colon adenoma number (data not shown; P . 0.05).
In the Omaha intercross mice, 129P2 alleles were detected at one marker unlinked to ERb (D3Mit203) and three markers linked to ERb (D12Mit60, D12Mit91 and D12Mit118) ( Table I ). Genotype at D3Mit203 had no impact on tumor multiplicity (P . 0.05; data not shown). This analysis is straightforward because D3Mit203 and ERb are unlinked. In contrast, evaluating the potentially confounding effects of 129P2 alleles at markers linked to the ERb knockout was complicated by the significant linkage disequilibrium. Genotype at ERb and the three markers proximal of ERb on chromosome 12 showed a high degree of concordance as follows: 93% for D12Mit91, 84% for D12Mit60 and 62% for D12Mit182. Thus, as much as 77 Mbp of the 129P2 genome on chromosome 12 is retained in association with the ERb knockout allele (Table I) .
Thus, both the Helsinki and the Omaha intercrosses were performed on a congenic B6 background in which only a single marker unlinked to ERb was still segregating 129P2 alleles. This uniform genetic background facilitates the interpretation of results because the possible impact of modifier loci unlinked to the ERb mutation can be discounted. However, there were significant differences between the ERb knockout mice used in these two crosses with respect to markers linked to ERb. In the Helsinki cross, the degree of linkage disequilibrium between the ERb knockout and linked 129P2 alleles is quite small, and the potential for linked modifiers is therefore minimal. In contrast, a larger block of 129P2 alleles that was retained in association with the ERb knockout in the Omaha cross. Although there is no direct evidence supporting the idea that a locus linked to ERb modifies tumorigenesis in Apc Min/þ mice, our observations prevent us from discounting this possibility.
ERb deficiency does not impact the levels of b-catenin, Cyclin D1, E-cadherin or ERa in the colonic mucosa Because ERb deficiency increased colon tumor incidence, we examined the impact of ERb deficiency on b-catenin expression and localization, the expression of Wnt-b-catenin target genes including Cyclin D1 and the interaction of b-catenin with the cell adhesion molecule E-cadherin. We used western blotting to analyze the levels of b-catenin, E-cadherin and Cyclin D1 in the nuclear and membrane fraction of the colonic mucosa of Apc Min/þ ERb þ/þ and Apc Min/þ ERb À/À mice. Additionally, we analyzed the impact of ERb deficiency on the expression of the ERa. Deletion of ERb had no effect on the expression of the nuclear b-catenin or Cyclin D1 or membrane b-catenin or E-cadherin (supplementary Figure 1 is available at Carcinogenesis Online). Furthermore, the expression of ERa protein was unaffected (supplementary Figure 1 available at Carcinogenesis Online). Thus, we found no evidence for ERb-dependent modulation of the Wnt pathway.
Discussion
In the present study, ERb deficiency did not increase adenoma multiplicity in Apc Min/þ mice. This lack of effect of ERb deficiency on total tumor multiplicity or small intestinal tumor multiplicity was confirmed in a second, independent cross involving the same ERb knockout allele (Esr2 Ksk1 ) and Apc Min/þ mice. This second cross was conducted at a separate institution using distinct husbandry conditions. A similar lack of effect of ERb deficiency on small intestinal tumorigenesis in Apc Min/þ mice was also reported by Cho et al. (18) in a study using a distinct ERb knockout allele (Esr2 Pcn1 ) (38). These three observations differ from that of Giroux et al. (19) , in which it is reported that deficiency of the Esr2 Pcn1 ERb knockout allele increased tumor multiplicity and size in female but not male Apc Min/þ mice. However, it should be noted that in the study of Giroux et al., female mice had been ovariectomized and implanted with E2 and progesterone pellets that result in continuous serum levels of these hormones in the high physiological range. In the two intercrosses we performed, as well as the study of Cho et al., ovary intact females were used. Consistent with the ovarian defects described previously in Apc Min/þ females (39), we observe that Apc Min/þ females have reduced serum levels of E2 and progesterone. Thus, there are significant differences in hormone levels between mice in these various studies. These differences may contribute to the disparate results observed.
In the present study, we observed that ERb deficiency was associated with an increased incidence of colon tumors in Apc Min/þ mice. Although our results differ from those described in Giroux et al. (19) , in which the Esr2 Pcn1 ERb knockout allele was found to have no impact on colon tumorigenesis in Apc Min/þ mice, our data are consistent with the study of Cho et al. (18) , which reported that homozygosity for the Esr2 Pcn1 ERb knockout allele increased colon tumor incidence in Apc Min/þ mice. In our study, we found that the increased incidence in colon tumors in ERb-deficient Apc Min/þ mice was not associated with enhanced activation of the Wnt-b-catenin pathway. These observations are consistent with a previous report (19) suggesting that ERb deficiency may promote intestinal tumorigenesis by modulating the transforming growth factor b pathway. Thus, our present studies using Apc Min/þ mice and a distinct ERb knockout (Esr2 Ksk1 ) help resolve the controversy regarding the impact of ERb on colon tumorigenesis and provide independent support for the hypothesis that ERb deficiency may promote tumorigenesis through a Wnt-b-catenin-independent pathway.
We also observed that genetic disruption of ERa in Apc Min/þ mice was associated with an increase in intestinal adenoma multiplicity, size and burden. These data are consistent with the hypothesis that loss of ERa expression contributes to intestinal tumorigenesis. Although the ERa knockout used here is a hypomorph, resulting in a truncated receptor (40) with a deleted amino-terminus and no activation function 1 domain but with some residual ligand binding and/or function, it is clear that disruption of ERa, even if incomplete, is associated with enhanced tumorigenesis Apc Min mice. It is noteworthy that when Cho et al. (18) crossed another ERa knockout (B6.129-Esr1 Pcn1 ), one reported to be a more complete disruption of ERa, with Apc Min/þ mice, no ERa À/À Apc Min/þ mice were recovered. One intriguing interpretation of this result is that there is a synthetic lethal interaction between the ERa allele and the Apc Min mutation. In our study, ERa À/À Apc Min/þ mice were recovered at the expected frequency.
Based on data from humans implicating ERa as a tumor suppressor in colon, we conclude that ERa deficiency itself is responsible for the enhanced tumorigenesis in ERa À/À Apc Min/þ mice. However, it is impossible to completely exclude the possibility that the enhanced tumorigenesis in ERa À/À Apc Min/þ mice is due to another allele that resides within the 129P2-derived region of ,13 Mbp on chromosome 10 that is retained in association with the ERa knockout allele. Less than a dozen genes map to this region, and none of these is known to modulate tumorigenesis in Apc Min/þ mice. The Scc14 locus, which modulates susceptibility to azoxymethane-induced colon cancer in a cross between the BALB/c and the CcS19/Dem strains, is linked to a marker 3.4 Mbp proximal of ERa (41). Nothing is known about 
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Min ratio values in normal intestinal epithelium of 80-day-old ERa þ/þ Apc Min/þ (n 5 6) and ERa À/À Apc Min/þ (n 5 6) mice is show (D). Each bar represents the mean ratio value ± SD. ER disruption enhances Min-induced tumorigenesis the impact of the 129P2 allele of Scc14 on colon cancer. Assuming that ERa and Scc14 represent distinct genes, we cannot exclude the possibility that the 129P2 allele of Scc14 increases tumor multiplicity in our cross. However, our previous studies provide no evidence that 129 substrains carry alleles that enhance tumorigenesis in Apc Min/þ mice. Rather, we have shown that the 129S2/SvPas substrain carries alleles that reduce tumor multiplicity in Apc Min/þ mice (27) . Additionally, in Oikarinen et al., in this issue of Carcinogenesis, we report the localization of Mom5, a modifier of tumorigenesis in Apc Min/þ mice; the 129P2 allele of Mom5 is associated with reduced tumor number. The impact of ERa deficiency was equivalent in Apc Min/þ males and females. These results are consistent with the fact that ERa expression is silenced in colorectal cancers in both men and women (13, 42) . Although ERa signaling reduces intestinal tumorigenesis in both male and female Apc Min/þ mice, it is unclear whether this effect requires endogenous estrogens or is ligand independent. Apc Min/þ females in our colony exhibit diminished ovarian function and low serum concentrations of E2 and progesterone. Although the physiological basis for the impact of the Min mutation of ovarian function is unknown, these observations, together with our observation that tumorigenesis in Apc Min/þ females is not influenced by ovariectomy (K.A.Gould, unpublished data), suggest that in our colony, ovarian estrogens do not play a role in ERa-dependent processes that attenuate tumorigenesis in Apc Min/þ mice.
We report that ERa deficiency in Apc Min/þ mice is associated with an accumulation of nuclear b-catenin, suggesting that ERa deficiency activates canonical Wnt-b-catenin signaling. The level of b-catenin in normal intestinal epithelium of ERa À/À Apc Min/þ mice is less than that in Apc Min -induced intestinal adenomas (K.A.Gould, unpublished data), suggesting that further activation of Wnt-b-catenin signaling occurs during tumorigenesis, probably as a consequence of loss of Apc þ , which occurs at a frequency of 100% in adenomas of B6 Apc Min/þ mice (11, 31) . Consistent with the hypothesis that ERa deficiency enhances Wnt-b-catenin signaling, the expression of the Wnt-b-catenin target genes Cyclin D1 and c-Myc was increased in the normal intestinal epithelium of ERa À/À Apc Min/þ mice. The expression of Cyclin D1 and c-Myc is regulated by many factors, including estrogens (43, 44) . Thus, it is possible that the increased expression of Cyclin D1 and c-Myc in ERa À/À Apc Min/þ epithelium is unrelated to Wnt-b-catenin activation. Nonetheless, the upregulation of these genes, which are known to play a role in colorectal cancer, indicates that ERa deficiency in Apc Min/þ mice is associated with increased expression of genes involved in intestinal tumorigenesis.
Although it is known that there is cross talk between the estrogen and the Wnt pathways in estrogen-responsive tissues such as the mammary gland (33) , further studies will be required to understand the molecular basis and significance of cross talk between ERa and Wnt signaling in the intestinal epithelium. In contrast to what is observed in the mammary gland, our studies suggest that Wnt and estrogen signaling have opposing effects in intestine, with Wnt signaling promoting tumorigenesis and ERa signaling inhibiting tumorigenesis.
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